The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system

被引:32
作者
Fox, JC
England, J
White, P
Ellison, G
Callaghan, K
Charlesworth, NR
Hehir, J
McCarthy, TL
Smith-Ravin, J
Talbot, IC
Snary, D
Northover, JMA
Newton, CR
Little, S
机构
[1] Zeneca Diagnost, Northwich CW9 7RA, Cheshire, England
[2] St Marks Hosp, Imperial Canc Res Fund, Colorectal Unit, Harrow HA1 3UJ, Middx, England
[3] St Bartholomews Hosp, Imperial Canc Res Fund, Appl Dev Lab, London EC1A 7BE, England
关键词
amplification-refractory mutation system; diagnosis; mutation; oncogene; screening;
D O I
10.1038/bjc.1998.212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A total of 301 colorectal carcinoma (CRC) archival samples were analysed using the amplification-refractory mutation system (ARMS). Each sample was examined to determine the mutation status of codons 12 and 13 of the K-ras oncogene. The results from direct DNA sequence analysis carried out on 30 of the samples differed from the ARMS result in almost 50% of the cases as a result of the relative excess of wild-type to mutated DNA sequences. To assess the validity of the ARMS data, the polymerase chain reaction (PGR) was used to generate an amplicon from K-ras exon I from 23 of the samples. The PCR amplicons were cloned and sequenced, and the DNA sequence analysis of the cloned material was in agreement with the ARMS results in all but one case. This case represented a tumour that exhibited a five-nucleotide reversed inversion. The cloned sequence data confirm the sensitivity and specificity of the individual ARMS reactions and that it is possible in certain cases to detect additional, more complex, sequence variations.
引用
收藏
页码:1267 / 1274
页数:8
相关论文
共 68 条
  • [1] *AM CANC SOC, 1986, CANC FACTS FIG 1996
  • [2] [Anonymous], NIH PUBLICATION
  • [3] PROGNOSTIC VALUE OF P53 OVEREXPRESSION AND C-KI-RAS GENE-MUTATIONS IN COLORECTAL-CANCER
    BELL, SM
    SCOTT, N
    CROSS, D
    SAGAR, P
    LEWIS, FA
    BLAIR, GE
    TAYLOR, GR
    DIXON, MF
    QUIRKE, P
    [J]. GASTROENTEROLOGY, 1993, 104 (01) : 57 - 64
  • [4] PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS
    BOS, JL
    FEARON, ER
    HAMILTON, SR
    VERLAANDEVRIES, M
    VANBOOM, JH
    VANDEREB, AJ
    VOGELSTEIN, B
    [J]. NATURE, 1987, 327 (6120) : 293 - 297
  • [5] BOS JL, 1989, CANCER RES, V49, P4682
  • [6] K-RAS MUTATION IN COLORECTAL-CANCER - RELATIONS TO PATIENT AGE, SEX AND TUMOR LOCATION
    BREIVIK, J
    MELING, GI
    SPURKLAND, A
    ROGNUM, TO
    GAUDERNACK, G
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 367 - 371
  • [7] MUTATIONS IN THE KRAS2 ONCOGENE DURING PROGRESSIVE STAGES OF HUMAN-COLON CARCINOMA
    BURMER, GC
    LOEB, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) : 2403 - 2407
  • [8] FREQUENCY AND SPECTRUM OF MUTATIONS AT CODON-12 AND CONDON-13 OF THE C-K-RAS GENE IN HUMAN TUMORS
    CAPELLA, G
    CRONAUERMITRA, S
    PEINADO, MA
    PERUCHO, M
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1991, 93 : 125 - 131
  • [9] Carpenter KM, 1996, CLIN CHEM, V42, P904
  • [10] Cha R S, 1992, PCR Methods Appl, V2, P14